Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study
Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension cent...
Saved in:
Published in | Archives of cardiovascular diseases Vol. 105; no. 12; pp. 623 - 630 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Masson SAS
01.12.2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Results Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32 ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR ≥ 32 ng/ng in the supine and/or upright position, sensitivity reached 100%. Conclusion The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA. |
---|---|
AbstractList | Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established.
The aim of the study was to establish the best biological predictors of APA.
A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP.
Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1hour supine and at least 1hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32ng/ng in the supine and/or upright position, sensitivity reached 100%.
The proposed cut-off value of 32ng/ng for ARR (minimum renin value set at 5ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA.
Les critères biologiques pour le diagnostic d’un adénome de Conn ne sont pas bien établi.
L’objectif de cette étude est d’établir les seuils biologiques d’aldostérone et de rénine permettant de prédire un adénome de Conn.
Un registre prospectif a été mis en œuvre dans 17 centres de l’hypertension. Le critère d’inclusion dans le registre était l’un des éléments suivants : apparition de l’hypertension avant 40ans, antécédent d’hypokaliémie, hypertension artérielle résistante ou efficacité trop importante de la spironolactone dans le traitement de l’hypertension.
Parmi les 338 cas recueillis, 192 patients ont eu deux déterminations successives de rénine et d’aldostérone (une heure en position couchée et au moins une heure debout). Vingt-cinq patients (8,2 %) avaient un hyperaldostéronisme biologique et un adénome surrénalien identifié par une tomodensitométrie. Une histologie compatible avec un adénome de Conn a été confirmée chez les les 12 patients qui ont été opérés. Un adénome de Conn histologiquement confirmé a été utilisé comme « gold standard » pour l’établissement des courbes ROC. Les rapports aldostérone/rénine (RAR) ont été calculés avec une valeur minimale de rénine fixée à 5ng/L. Afin de prédire un adénome de Conn, l’aire sous la courbe ROC du RAR était de 0,93. Une valeur de RAR couchée supérieure à 32ng/ng avait les sensibilités (92 %) et spécificité (92 %) les plus élevées. Sur la base d’un RAR supérieur à 32ng/ng en décubitus dorsal et/ou en orthostatisme, la sensibilité atteint 100 %.
Le seuil de RAR à 32ng/ng (valeur minimale de rénine à 5ng/L) lors de l’une des deux déterminations, soit en décubitus dorsal, soit en orthostatisme a une sensibilité de 100 %, une spécificité de 72 %, une valeur prédictive positive de 20 % et une valeur prédictive négative de 100 % pour le diagnostic d’un adénome de Conn. BACKGROUNDBiological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established.AIMThe aim of the study was to establish the best biological predictors of APA.METHODSA prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP.RESULTSAmong the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the 'gold standard' in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called 'low-renin hypertension'. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32 ng/ng in the supine and/or upright position, sensitivity reached 100%.CONCLUSIONThe proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA. Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. The aim of the study was to establish the best biological predictors of APA. A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the 'gold standard' in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called 'low-renin hypertension'. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR≥32 ng/ng in the supine and/or upright position, sensitivity reached 100%. The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA. Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to establish the best biological predictors of APA. Methods A prospective register was implemented in 17 secondary or tertiary hypertension centres. The inclusion criterion was one of the following: onset of hypertension before 40 years of age; history of hypokalaemia; drug-resistant hypertension (resistant to three drugs); or spironolactone efficiency on BP. Results Among the 338 collected cases, 192 patients had two aldosterone-to-renin ratio (ARR) determinations (after 1 hour supine and at least 1 hour upright) on the same occasion. Twenty-five patients (8.2%) had biological hyperaldosteronism and an adrenal adenoma identified by computed tomography. APA was histologically confirmed in all 12 patients who underwent surgery. Histologically proven APAs were used as the ‘gold standard’ in receiver operating characteristic (ROC) curve analysis. ARRs were computed with a minimum renin value set at 5 ng/L to avoid misclassification of so-called ‘low-renin hypertension’. To predict an APA, the ARR area under the ROC curve was 0.93. A supine ARR cut-off value of 32 ng/ng provided the highest sum of sensitivity (92%) plus specificity (92%). On the basis of an ARR ≥ 32 ng/ng in the supine and/or upright position, sensitivity reached 100%. Conclusion The proposed cut-off value of 32 ng/ng for ARR (minimum renin value set at 5 ng/L) in one of two determinations had 100% sensitivity and 72% specificity with 20% positive and 100% negative predictive values for diagnosing APA. |
Author | Jabourek, Olivier Sosner, Philippe Régnier-Le Coz, Sylvie Fauvel, Jean-Pierre Tartière, Jean-Michel Mounier-Véhier, Claire Lejeune, Sylvain Perez, Laurence Baguet, Jean-Philippe Fourcade, Jacques Ducher, Michel Stolz, Arnaud |
Author_xml | – sequence: 1 fullname: Ducher, Michel – sequence: 2 fullname: Mounier-Véhier, Claire – sequence: 3 fullname: Baguet, Jean-Philippe – sequence: 4 fullname: Tartière, Jean-Michel – sequence: 5 fullname: Sosner, Philippe – sequence: 6 fullname: Régnier-Le Coz, Sylvie – sequence: 7 fullname: Perez, Laurence – sequence: 8 fullname: Fourcade, Jacques – sequence: 9 fullname: Jabourek, Olivier – sequence: 10 fullname: Lejeune, Sylvain – sequence: 11 fullname: Stolz, Arnaud – sequence: 12 fullname: Fauvel, Jean-Pierre |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26669554$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23199617$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1r3DAQhkVJaT7aP9BD8aXQi119WJIdSmEJSVsI9NDmFhBaaRy0saVEkgP77yN3N2nooScN4nlnhmeO0YEPHhB6T3BDMBGfN402D7ahmNAGywZj8QodkU7ymhLaHTzXTByi45Q2BaBSijfokDLS94LII3S9Gm1IGWJpXedQR_DOV1FnF6ohxMo6feNDcv6m0i_IuxjsbP78WvBh0qfVqprmMTsDPkeoUp7t9i16Pegxwbv9e4KuLs5_n32vL39--3G2uqwNxzLXPdeDpmwAXRYWHQjSgdbQD7jDgnNBicSUacJ6xnDbi3Ur1xZ4P0gDayM7doI-7fqWte5nSFlNLhkYR-0hzEkRSknHMWvbgtIdamJIKcKg7qKbdNwqgtViVW3UYlUtVhWWqkgroQ_7_vN6AvscedJYgI97QCejxyFqb1z6ywkhes6X6V92HBQbDw6iSsaBN2BdBJOVDe7_e3z9J25G512ZeAtbSJswR188K6JSyahfy_2X8xOKMW15xx4BCUOsqw |
CitedBy_id | crossref_primary_10_1097_HJH_0000000000000076 crossref_primary_10_1177_1470320320919610 crossref_primary_10_1155_2020_3934212 crossref_primary_10_1007_s40292_017_0200_9 crossref_primary_10_1080_08037051_2024_2350981 crossref_primary_10_1097_HJH_0000000000000367 crossref_primary_10_1530_EJE_14_0537 crossref_primary_10_1053_j_ackd_2015_03_002 crossref_primary_10_1111_jch_13041 crossref_primary_10_1507_endocrj_EJ21_0508 crossref_primary_10_1016_j_ando_2016_02_003 crossref_primary_10_1210_clinem_dgac654 crossref_primary_10_1016_j_amjms_2016_06_015 crossref_primary_10_3389_fendo_2021_647184 crossref_primary_10_1016_j_acvd_2014_09_011 crossref_primary_10_2169_internalmedicine_3116_23 |
Cites_doi | 10.1001/archinternmed.2007.33 10.1001/jama.295.22.2638 10.1016/j.amjhyper.2005.05.013 10.1080/10641960802443282 10.1161/HYPERTENSIONAHA.110.168484 10.1210/jc.2011-2830 10.1111/j.1440-1681.1994.tb02519.x 10.1093/ndt/gfh112 10.1097/HJH.0b013e3282f61f8c 10.2215/CJN.01060306 10.1111/j.1445-5994.1976.tb03306.x 10.1016/S0140-6736(00)04223-9 10.1016/j.amjhyper.2005.01.002 10.1161/HYPERTENSIONAHA.109.139832 10.1097/HJH.0b013e328350225d 10.1007/s11154-011-9162-8 10.1016/S0140-6736(05)74868-6 10.1016/j.jacc.2006.07.059 10.1097/00004872-200311000-00025 10.1681/ASN.2004100878 10.1097/HJH.0b013e32834666af 10.1007/s11154-011-9160-x 10.1210/jc.2004-1149 10.1210/jc.2003-031337 10.1373/clinchem.2004.041780 10.1161/01.HYP.0000230444.01215.6a 10.1161/HYPERTENSIONAHA.106.086116 10.1210/jc.2008-0104 10.1097/01.hjh.0000217857.20241.0f 10.1097/HJH.0b013e32833d2192 10.1016/j.jacc.2005.01.015 10.1161/01.HYP.0000079505.25750.11 |
ContentType | Journal Article |
Copyright | Elsevier Masson SAS 2012 Elsevier Masson SAS 2014 INIST-CNRS Copyright © 2012 Elsevier Masson SAS. All rights reserved. |
Copyright_xml | – notice: Elsevier Masson SAS – notice: 2012 Elsevier Masson SAS – notice: 2014 INIST-CNRS – notice: Copyright © 2012 Elsevier Masson SAS. All rights reserved. |
DBID | 6I. AAFTH IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.acvd.2012.07.006 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Le rapport aldostérone/rénine pour diagnostiquer un adénome de Conn : une étude multicentrique |
EISSN | 1875-2128 |
EndPage | 630 |
ExternalDocumentID | 10_1016_j_acvd_2012_07_006 23199617 26669554 S1875213612002458 1_s2_0_S1875213612002458 |
Genre | Multicenter Study Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 1B1 1P~ 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 6I. 6J9 7-5 71M 8P~ AACTN AAEDT AAEDW AAFTH AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABVKL ABXDB ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADMUD ADVLN AEBSH AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BAWUL BKOJK BLXMC BNPGV CS3 DIK EBS EFJIC EJD EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ IXB J1W KOM LN9 M41 MO0 N9A NCXOZ O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 PC. Q38 RIG ROL SDF SDG SEM SES SPCBC SSH SSZ T5K UNMZH Z5R ~G- AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AALMO ABPIF ABQIS ADALY IPNFZ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c507t-95afa23fea18768e618eaae9f0806556217023a139330496b47bde59f7cebc783 |
IEDL.DBID | IXB |
ISSN | 1875-2136 |
IngestDate | Fri Oct 25 06:16:57 EDT 2024 Thu Sep 26 19:52:08 EDT 2024 Sat Sep 28 08:00:11 EDT 2024 Thu Nov 24 18:26:35 EST 2022 Fri Feb 23 02:20:48 EST 2024 Tue Oct 15 22:54:14 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Hypertension computed tomography ARR blood pressure Adénome de Conn Aldosterone-producing adenoma ROC Aldosterone BP CT PA APA Renin Hypokalaemia Hypokaliémie adrenal venous sampling Rapport aldostérone-rénine primary aldosteronism Aldosteronism Aldosterone-to-renin ratio receiver operating characteristic Rénine AVS Endocrinopathy Hydroelectrolytic balance disorder Adrenal cortex diseases Enzyme Cardiovascular disease Hyperadrenocorticism Adenoma Inorganic element Peptidases Metabolic disorder Conn syndrome Adrenal gland diseases Hydrolases Aspartic endopeptidases Hypokaliemia Ratio Benign neoplasm Diagnosis Cardiology Potassium |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 Copyright © 2012 Elsevier Masson SAS. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c507t-95afa23fea18768e618eaae9f0806556217023a139330496b47bde59f7cebc783 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1875213612002458 |
PMID | 23199617 |
PQID | 1221850344 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1221850344 crossref_primary_10_1016_j_acvd_2012_07_006 pubmed_primary_23199617 pascalfrancis_primary_26669554 elsevier_sciencedirect_doi_10_1016_j_acvd_2012_07_006 elsevier_clinicalkeyesjournals_1_s2_0_S1875213612002458 |
PublicationCentury | 2000 |
PublicationDate | 2012-12-01 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Archives of cardiovascular diseases |
PublicationTitleAlternate | Arch Cardiovasc Dis |
PublicationYear | 2012 |
Publisher | Elsevier Masson SAS Elsevier |
Publisher_xml | – name: Elsevier Masson SAS – name: Elsevier |
References | Rossi (bib0135) 2011; 12 Catena, Colussi, Nadalini (bib0040) 2008; 168 Niizuma, Nakahama, Kamide (bib0090) 2008; 30 Kaplan (bib0140) 2011; 12 Rossi, Barisa, Belfiore (bib0125) 2010; 28 Gordon, Stowasser, Tunny (bib0015) 1994; 21 Rossi, Barisa, Allolio (bib0160) 2012; 97 Mulatero, Stowasser, Loh (bib0030) 2004; 89 Rossi, Bernini, Desideri (bib0060) 2006; 48 Schwartz, Turner (bib0105) 2005; 51 Calhoun (bib0070) 2006; 1 Tiu, Choi, Shek (bib0110) 2005; 90 Mosso, Carvajal, Gonzalez (bib0075) 2003; 42 Sechi, Novello, Lapenna (bib0065) 2006; 295 Plouin, Amar, Chatellier (bib0100) 2004; 19 Giacchetti, Ronconi, Lucarelli (bib0085) 2006; 24 Dunn, Espiner (bib0080) 1976; 6 Sarlon-Bartoli, Michel, Taieb (bib0155) 2011; 29 Kaplan (bib0020) 2001; 357 Funder, Carey, Fardella (bib0150) 2008; 93 Stowasser, Gordon, Gunasekera (bib0035) 2003; 21 Rossi, Bernini, Caliumi (bib0005) 2006; 48 Calhoun (bib0010) 2007; 50 Matsumura, Fujii, Oniki (bib0045) 2006; 19 Lim, Rodgers, Cardale (bib0025) 1999; 353 Vonend, Ockenfels, Gao (bib0165) 2011; 57 Kaplan (bib0115) 2005 van der Linden, Steichen, Zinzindohoue (bib0130) 2012; 30 Nishizaka, Pratt-Ubunama, Zaman (bib0095) 2005; 18 Bernini, Moretti, Orlandini (bib0120) 2008; 26 Ribstein, Du Cailar, Fesler (bib0055) 2005; 16 Rossi, Seccia, Palumbo (bib0145) 2010; 55 Milliez, Girerd, Plouin (bib0050) 2005; 45 Rossi (10.1016/j.acvd.2012.07.006_bib0160) 2012; 97 van der Linden (10.1016/j.acvd.2012.07.006_bib0130) 2012; 30 Mulatero (10.1016/j.acvd.2012.07.006_bib0030) 2004; 89 Lim (10.1016/j.acvd.2012.07.006_bib0025) 1999; 353 Plouin (10.1016/j.acvd.2012.07.006_bib0100) 2004; 19 Schwartz (10.1016/j.acvd.2012.07.006_bib0105) 2005; 51 Kaplan (10.1016/j.acvd.2012.07.006_bib0115) 2005 Matsumura (10.1016/j.acvd.2012.07.006_bib0045) 2006; 19 Kaplan (10.1016/j.acvd.2012.07.006_bib0020) 2001; 357 Milliez (10.1016/j.acvd.2012.07.006_bib0050) 2005; 45 Gordon (10.1016/j.acvd.2012.07.006_bib0015) 1994; 21 Rossi (10.1016/j.acvd.2012.07.006_bib0060) 2006; 48 Mosso (10.1016/j.acvd.2012.07.006_bib0075) 2003; 42 Niizuma (10.1016/j.acvd.2012.07.006_bib0090) 2008; 30 Dunn (10.1016/j.acvd.2012.07.006_bib0080) 1976; 6 Rossi (10.1016/j.acvd.2012.07.006_bib0005) 2006; 48 Calhoun (10.1016/j.acvd.2012.07.006_bib0010) 2007; 50 Catena (10.1016/j.acvd.2012.07.006_bib0040) 2008; 168 Sarlon-Bartoli (10.1016/j.acvd.2012.07.006_bib0155) 2011; 29 Funder (10.1016/j.acvd.2012.07.006_bib0150) 2008; 93 Rossi (10.1016/j.acvd.2012.07.006_bib0125) 2010; 28 Calhoun (10.1016/j.acvd.2012.07.006_bib0070) 2006; 1 Stowasser (10.1016/j.acvd.2012.07.006_bib0035) 2003; 21 Sechi (10.1016/j.acvd.2012.07.006_bib0065) 2006; 295 Kaplan (10.1016/j.acvd.2012.07.006_bib0140) 2011; 12 Vonend (10.1016/j.acvd.2012.07.006_bib0165) 2011; 57 Nishizaka (10.1016/j.acvd.2012.07.006_bib0095) 2005; 18 Ribstein (10.1016/j.acvd.2012.07.006_bib0055) 2005; 16 Rossi (10.1016/j.acvd.2012.07.006_bib0145) 2010; 55 Bernini (10.1016/j.acvd.2012.07.006_bib0120) 2008; 26 Rossi (10.1016/j.acvd.2012.07.006_bib0135) 2011; 12 Giacchetti (10.1016/j.acvd.2012.07.006_bib0085) 2006; 24 Tiu (10.1016/j.acvd.2012.07.006_bib0110) 2005; 90 |
References_xml | – volume: 57 start-page: 990 year: 2011 end-page: 995 ident: bib0165 article-title: Adrenal venous sampling: evaluation of the German Conn's registry publication-title: Hypertension contributor: fullname: Gao – volume: 357 start-page: 953 year: 2001 end-page: 954 ident: bib0020 article-title: Cautions over the current epidemic of primary aldosteronism publication-title: Lancet contributor: fullname: Kaplan – volume: 30 start-page: 640 year: 2008 end-page: 647 ident: bib0090 article-title: The cut-off value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine publication-title: Clin Exp Hypertens contributor: fullname: Kamide – volume: 97 start-page: 1606 year: 2012 end-page: 1614 ident: bib0160 article-title: The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism publication-title: J Clin Endocrinol Metab contributor: fullname: Allolio – volume: 19 start-page: 774 year: 2004 end-page: 777 ident: bib0100 article-title: Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension publication-title: Nephrol Dial Transplant contributor: fullname: Chatellier – volume: 21 start-page: 315 year: 1994 end-page: 318 ident: bib0015 article-title: High incidence of primary aldosteronism in 199 patients referred with hypertension publication-title: Clin Exp Pharmacol Physiol contributor: fullname: Tunny – volume: 45 start-page: 1243 year: 2005 end-page: 1248 ident: bib0050 article-title: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism publication-title: J Am Coll Cardiol contributor: fullname: Plouin – volume: 26 start-page: 981 year: 2008 end-page: 988 ident: bib0120 article-title: Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism publication-title: J Hypertens contributor: fullname: Orlandini – volume: 6 start-page: 131 year: 1976 end-page: 135 ident: bib0080 article-title: Outpatient screening tests for primary aldosteronism publication-title: Aust N Z J Med contributor: fullname: Espiner – volume: 90 start-page: 72 year: 2005 end-page: 78 ident: bib0110 article-title: The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling publication-title: J Clin Endocrinol Metab contributor: fullname: Shek – volume: 295 start-page: 2638 year: 2006 end-page: 2645 ident: bib0065 article-title: Long-term renal outcomes in patients with primary aldosteronism publication-title: JAMA contributor: fullname: Lapenna – volume: 50 start-page: 447 year: 2007 end-page: 453 ident: bib0010 article-title: Is there an unrecognized epidemic of primary aldosteronism? publication-title: Pro Hypertens contributor: fullname: Calhoun – volume: 55 start-page: 83 year: 2010 end-page: 89 ident: bib0145 article-title: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism publication-title: Hypertension contributor: fullname: Palumbo – volume: 48 start-page: 2293 year: 2006 end-page: 2300 ident: bib0005 article-title: A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients publication-title: J Am Coll Cardiol contributor: fullname: Caliumi – volume: 48 start-page: 232 year: 2006 end-page: 238 ident: bib0060 article-title: Renal damage in primary aldosteronism: results of the PAPY Study publication-title: Hypertension contributor: fullname: Desideri – volume: 89 start-page: 1045 year: 2004 end-page: 1050 ident: bib0030 article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents publication-title: J Clin Endocrinol Metab contributor: fullname: Loh – volume: 21 start-page: 2149 year: 2003 end-page: 2157 ident: bib0035 article-title: High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients publication-title: J Hypertens contributor: fullname: Gunasekera – volume: 12 start-page: 27 year: 2011 end-page: 36 ident: bib0135 article-title: Diagnosis and treatment of primary aldosteronism publication-title: Rev Endocr Metab Disord contributor: fullname: Rossi – volume: 30 start-page: 761 year: 2012 end-page: 769 ident: bib0130 article-title: Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study publication-title: J Hypertens contributor: fullname: Zinzindohoue – volume: 18 start-page: 805 year: 2005 end-page: 812 ident: bib0095 article-title: Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension publication-title: Am J Hypertens contributor: fullname: Zaman – volume: 353 start-page: 40 year: 1999 ident: bib0025 article-title: Potentially high prevalence of primary aldosteronism in a primary-care population publication-title: Lancet contributor: fullname: Cardale – volume: 1 start-page: 1039 year: 2006 end-page: 1045 ident: bib0070 article-title: Aldosteronism and hypertension publication-title: Clin J Am Soc Nephrol contributor: fullname: Calhoun – volume: 51 start-page: 386 year: 2005 end-page: 394 ident: bib0105 article-title: Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity publication-title: Clin Chem contributor: fullname: Turner – volume: 29 start-page: 1196 year: 2011 end-page: 1202 ident: bib0155 article-title: Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography publication-title: J Hypertens contributor: fullname: Taieb – year: 2005 ident: bib0115 article-title: Primary aldosteronism publication-title: Kaplan's Clinical Hypertension contributor: fullname: Kaplan – volume: 24 start-page: 737 year: 2006 end-page: 745 ident: bib0085 article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol publication-title: J Hypertens contributor: fullname: Lucarelli – volume: 168 start-page: 80 year: 2008 end-page: 85 ident: bib0040 article-title: Cardiovascular outcomes in patients with primary aldosteronism after treatment publication-title: Arch Intern Med contributor: fullname: Nadalini – volume: 42 start-page: 161 year: 2003 end-page: 165 ident: bib0075 article-title: Primary aldosteronism and hypertensive disease publication-title: Hypertension contributor: fullname: Gonzalez – volume: 12 start-page: 49 year: 2011 end-page: 52 ident: bib0140 article-title: Primary aldosteronism: a contrarian view publication-title: Rev Endocr Metab Disord contributor: fullname: Kaplan – volume: 28 start-page: 1892 year: 2010 end-page: 1899 ident: bib0125 article-title: The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma publication-title: J Hypertens contributor: fullname: Belfiore – volume: 16 start-page: 1320 year: 2005 end-page: 1325 ident: bib0055 article-title: Relative glomerular hyperfiltration in primary aldosteronism publication-title: J Am Soc Nephrol contributor: fullname: Fesler – volume: 19 start-page: 13 year: 2006 end-page: 18 ident: bib0045 article-title: Role of aldosterone in left ventricular hypertrophy in hypertension publication-title: Am J Hypertens contributor: fullname: Oniki – volume: 93 start-page: 3266 year: 2008 end-page: 3281 ident: bib0150 article-title: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metab contributor: fullname: Fardella – volume: 168 start-page: 80 year: 2008 ident: 10.1016/j.acvd.2012.07.006_bib0040 article-title: Cardiovascular outcomes in patients with primary aldosteronism after treatment publication-title: Arch Intern Med doi: 10.1001/archinternmed.2007.33 contributor: fullname: Catena – volume: 295 start-page: 2638 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0065 article-title: Long-term renal outcomes in patients with primary aldosteronism publication-title: JAMA doi: 10.1001/jama.295.22.2638 contributor: fullname: Sechi – volume: 19 start-page: 13 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0045 article-title: Role of aldosterone in left ventricular hypertrophy in hypertension publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2005.05.013 contributor: fullname: Matsumura – year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0115 article-title: Primary aldosteronism contributor: fullname: Kaplan – volume: 30 start-page: 640 year: 2008 ident: 10.1016/j.acvd.2012.07.006_bib0090 article-title: The cut-off value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine publication-title: Clin Exp Hypertens doi: 10.1080/10641960802443282 contributor: fullname: Niizuma – volume: 57 start-page: 990 year: 2011 ident: 10.1016/j.acvd.2012.07.006_bib0165 article-title: Adrenal venous sampling: evaluation of the German Conn's registry publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.110.168484 contributor: fullname: Vonend – volume: 97 start-page: 1606 year: 2012 ident: 10.1016/j.acvd.2012.07.006_bib0160 article-title: The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-2830 contributor: fullname: Rossi – volume: 21 start-page: 315 year: 1994 ident: 10.1016/j.acvd.2012.07.006_bib0015 article-title: High incidence of primary aldosteronism in 199 patients referred with hypertension publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/j.1440-1681.1994.tb02519.x contributor: fullname: Gordon – volume: 19 start-page: 774 year: 2004 ident: 10.1016/j.acvd.2012.07.006_bib0100 article-title: Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfh112 contributor: fullname: Plouin – volume: 26 start-page: 981 year: 2008 ident: 10.1016/j.acvd.2012.07.006_bib0120 article-title: Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism publication-title: J Hypertens doi: 10.1097/HJH.0b013e3282f61f8c contributor: fullname: Bernini – volume: 1 start-page: 1039 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0070 article-title: Aldosteronism and hypertension publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.01060306 contributor: fullname: Calhoun – volume: 6 start-page: 131 year: 1976 ident: 10.1016/j.acvd.2012.07.006_bib0080 article-title: Outpatient screening tests for primary aldosteronism publication-title: Aust N Z J Med doi: 10.1111/j.1445-5994.1976.tb03306.x contributor: fullname: Dunn – volume: 357 start-page: 953 year: 2001 ident: 10.1016/j.acvd.2012.07.006_bib0020 article-title: Cautions over the current epidemic of primary aldosteronism publication-title: Lancet doi: 10.1016/S0140-6736(00)04223-9 contributor: fullname: Kaplan – volume: 18 start-page: 805 year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0095 article-title: Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2005.01.002 contributor: fullname: Nishizaka – volume: 55 start-page: 83 year: 2010 ident: 10.1016/j.acvd.2012.07.006_bib0145 article-title: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.109.139832 contributor: fullname: Rossi – volume: 30 start-page: 761 year: 2012 ident: 10.1016/j.acvd.2012.07.006_bib0130 article-title: Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study publication-title: J Hypertens doi: 10.1097/HJH.0b013e328350225d contributor: fullname: van der Linden – volume: 12 start-page: 27 year: 2011 ident: 10.1016/j.acvd.2012.07.006_bib0135 article-title: Diagnosis and treatment of primary aldosteronism publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-011-9162-8 contributor: fullname: Rossi – volume: 353 start-page: 40 year: 1999 ident: 10.1016/j.acvd.2012.07.006_bib0025 article-title: Potentially high prevalence of primary aldosteronism in a primary-care population publication-title: Lancet doi: 10.1016/S0140-6736(05)74868-6 contributor: fullname: Lim – volume: 48 start-page: 2293 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0005 article-title: A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.07.059 contributor: fullname: Rossi – volume: 21 start-page: 2149 year: 2003 ident: 10.1016/j.acvd.2012.07.006_bib0035 article-title: High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients publication-title: J Hypertens doi: 10.1097/00004872-200311000-00025 contributor: fullname: Stowasser – volume: 16 start-page: 1320 year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0055 article-title: Relative glomerular hyperfiltration in primary aldosteronism publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004100878 contributor: fullname: Ribstein – volume: 29 start-page: 1196 year: 2011 ident: 10.1016/j.acvd.2012.07.006_bib0155 article-title: Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography publication-title: J Hypertens doi: 10.1097/HJH.0b013e32834666af contributor: fullname: Sarlon-Bartoli – volume: 12 start-page: 49 year: 2011 ident: 10.1016/j.acvd.2012.07.006_bib0140 article-title: Primary aldosteronism: a contrarian view publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-011-9160-x contributor: fullname: Kaplan – volume: 90 start-page: 72 year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0110 article-title: The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1149 contributor: fullname: Tiu – volume: 89 start-page: 1045 year: 2004 ident: 10.1016/j.acvd.2012.07.006_bib0030 article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031337 contributor: fullname: Mulatero – volume: 51 start-page: 386 year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0105 article-title: Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity publication-title: Clin Chem doi: 10.1373/clinchem.2004.041780 contributor: fullname: Schwartz – volume: 48 start-page: 232 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0060 article-title: Renal damage in primary aldosteronism: results of the PAPY Study publication-title: Hypertension doi: 10.1161/01.HYP.0000230444.01215.6a contributor: fullname: Rossi – volume: 50 start-page: 447 year: 2007 ident: 10.1016/j.acvd.2012.07.006_bib0010 article-title: Is there an unrecognized epidemic of primary aldosteronism? publication-title: Pro Hypertens doi: 10.1161/HYPERTENSIONAHA.106.086116 contributor: fullname: Calhoun – volume: 93 start-page: 3266 year: 2008 ident: 10.1016/j.acvd.2012.07.006_bib0150 article-title: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0104 contributor: fullname: Funder – volume: 24 start-page: 737 year: 2006 ident: 10.1016/j.acvd.2012.07.006_bib0085 article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol publication-title: J Hypertens doi: 10.1097/01.hjh.0000217857.20241.0f contributor: fullname: Giacchetti – volume: 28 start-page: 1892 year: 2010 ident: 10.1016/j.acvd.2012.07.006_bib0125 article-title: The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma publication-title: J Hypertens doi: 10.1097/HJH.0b013e32833d2192 contributor: fullname: Rossi – volume: 45 start-page: 1243 year: 2005 ident: 10.1016/j.acvd.2012.07.006_bib0050 article-title: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.01.015 contributor: fullname: Milliez – volume: 42 start-page: 161 year: 2003 ident: 10.1016/j.acvd.2012.07.006_bib0075 article-title: Primary aldosteronism and hypertensive disease publication-title: Hypertension doi: 10.1161/01.HYP.0000079505.25750.11 contributor: fullname: Mosso |
SSID | ssj0062776 |
Score | 2.0747585 |
Snippet | Summary Background Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. Aim The aim of the study was to... Biological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established. The aim of the study was to establish the best... BACKGROUNDBiological diagnostic criteria for diagnosing aldosterone-producing adenoma (APA) are not well-established.AIMThe aim of the study was to establish... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 623 |
SubjectTerms | Adenoma - blood Adenoma - diagnosis Adenoma - metabolism Adrenal Gland Neoplasms - blood Adrenal Gland Neoplasms - diagnosis Adrenal Gland Neoplasms - metabolism Adrenals. Adrenal axis. Renin-angiotensin system (diseases) Adénome de Conn Aldosterone Aldosterone - biosynthesis Aldosterone - blood Aldosterone-producing adenoma Aldosterone-to-renin ratio Aldosteronism Arterial hypertension. Arterial hypotension Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular Endocrinopathies Female Humans Hypertension Hypokalaemia Hypokaliémie Internal Medicine Male Medical sciences Middle Aged Non tumoral diseases. Target tissue resistance. Benign neoplasms Prospective Studies Rapport aldostérone-rénine Renin Renin - blood Rénine |
Title | Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: A multicentre study |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1875213612002458 https://dx.doi.org/10.1016/j.acvd.2012.07.006 https://www.ncbi.nlm.nih.gov/pubmed/23199617 https://search.proquest.com/docview/1221850344 |
Volume | 105 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEB48QAQRb-NRVvBN1nZzbBrfalHqVR88KCIsm2QDFU2LrT76253ZJB6IPvhUEjbtMJPM9zXzzSzALnLwBIE94PhPx3A_S2OudTPmbkJFLkRsKahR-KIrOzf-aS_oTUC76oUhWWWZ-4ucbrN1eaZeerM-7PfrVwKptis8hGhbP6SGXy8Qtomvd1hlY-mGdoM5Wsxpddk4U2i8dPJK00LpfSBNMpS_gdPcUI_QZVmx18XvZNSC0vECzJdskrUKgxdhwuRLMHNR1suX4b71mFIXx_MgN3w84CSty5kNOkO2ytJCaIfwxfSXlUM7BtaexbQ0eNIHrMWs9NBqOQ2zQ2lX4Ob46Lrd4eV-CjxB1jfmUaAz7XqZ0egN2TRSNI3WJsoaVF1FIiRCRHCNnJBeckQy9sM4NUGUhYmJMXbeKkzlaMU6MAx9w-gojhBi_Wbq4hd5yEQasZ9mXmg8B_YqR6phMTZDVXqyB0VuV-R21aDqt3QgrHytqoZQTGFmVD5PIyXUCBerHzF3IPi48tttoxAR_vzF2reQfhiJfEVGSLEc2KlirPCBoyqKzs3gBU1xkRUFNCnRgbUi-J9XeyTqFuHGP83ahFk6KuQyWzA1fn4x20h6xnENJvffRA2mW4e3Z-f0eXLW6dbsvY5H3Xbv8u4dIZcEyw |
link.rule.ids | 315,783,787,3513,4509,24128,27581,27936,27937,45597,45675,45691,45886 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QAURb-sZwTcJu73S1rdFlPXYfXEFH4SQtimsaHfZw9_vTJqqi-iDr23SDjPNzNfMNxOAM8TgGQb2kOOfjuZBkadcqTjlXkZJLozYwqVC4U5XtB-D26fwaQ4u61oYolVa31_5dOOt7ZWG1WZj2O83HlyE2p7rY4g2-cN4Hhbx2QmuzsXWzV27Wztk4UXmjDkaz2mCrZ2paF4qe6eGobQlSM0MxW_xaXWoxqi1ojru4nc8auLS9TqsWUDJWpXMGzCny01Y6tiU-RY8t15zKuQYDUrNJwNO7LqSGbszBKwsr7h2GMGY-jZyaDrBmqvomQZv6oK1mGEfGjqnZqYv7TY8Xl_1LtvcHqnAMwR-E56EqlCeX2iF2hCxFm6sldJJ0aQEK2IhN8IgrhAW0j5HItIgSnMdJkWU6RTN5-_AQolS7AFD6ze1StIEo2wQ5x4-yEcw0kyDvPAj7TtwXitSDqvOGbKmlL1IUrsktcsmJcCFA1Gta1nXhKIX02O7pMbSlWMcLH-Y3YHwc-bMlyMxKPz5xuMZk34KiZBFJIiyHDitbSxxzVEiRZV6MEVRPARGITVLdGC3Mv7XbJ943W60_0-xTmC53evcy_ub7t0BrNCdij1zCAuT0VQfIQaapMf2G_8AuMwDMw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aldosterone-to-renin+ratio+for+diagnosing+aldosterone-producing+adenoma%3A+a+multicentre+study&rft.jtitle=Archives+of+cardiovascular+diseases&rft.au=Ducher%2C+Michel&rft.au=Mounier-V%C3%A9hier%2C+Claire&rft.au=Baguet%2C+Jean-Philippe&rft.au=Tarti%C3%A8re%2C+Jean-Michel&rft.date=2012-12-01&rft.eissn=1875-2128&rft.volume=105&rft.issue=12&rft.spage=623&rft_id=info:doi/10.1016%2Fj.acvd.2012.07.006&rft_id=info%3Apmid%2F23199617&rft.externalDocID=23199617 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F18752136%2FS1875213612X00111%2Fcov150h.gif |